Valbiotis SA (FR:ALVAL) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Valbiotis, a French laboratory specializing in dietary supplements aimed at preventing metabolic disorders, has disclosed its share capital structure for May 2024, with 15,794,596 shares and 16,510,598 exercisable voting rights. The company reminds shareholders of the obligation to declare share ownership thresholds exceeding 5%, under penalty of losing voting rights. Valbiotis continues to innovate in health supplements, with a strong academic partnership presence and support from the European Union.
For further insights into FR:ALVAL stock, check out TipRanks’ Stock Analysis page.